Financial statements Diagnostyka Oncogene
Cash flow statement of Diagnostyka Oncogene
Company age:
Age:
15 y. 29 d.
Share capital:
Share capital:
12 000 PLN
Cash inflows of DIAGNOSTYKA ONCOGENE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | - | - | - | - | - | 5 491 215,89 |
| Net cash flow from investing activities | - | - | - | - | - | -139 771,64 |
| Net cash flow from financial activities | - | - | - | - | - | -2 700 000,00 |
| Total net cash flow | - | - | - | - | - | 2 651 444,25 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.